Abstract:Objective: Restoring intracellular cGMP and inducing NO-synthesis attenuates ischemia-associated early pulmonary allograft dysfunction. Phosphodiesterase-5 (PDE), predominantly expressed in lung tissue, plays a pivotal role in modulating the cGMP/NO-synthase pathway in endothelial and epithelial cells. In this study, we evaluate the effect of employing sildenafil (Viagra (R)), a specific inhibitor of PDE-5, to counteract ischemia/reperfusion (I/R) injury in a single lung transplantation model of extended ischemia. Methods: Donor animals (weight matched outbred pigs, 28-35 kg) in the treatment group (1) (n = 5) were injected with 0.7 mg sildenafil/kg into the pulmonary artery (PA) prior to inflow occlusion. For perfusion, Perfadex (R)), containing 0.7 mg sildenafil/l was used, and the graft stored at 1 degrees C in the per-fusion solution. After 24 h ischemia, unilateral left lung transplantation was performed. Starting at reperfusion, group I received continuous sildenafil (0.7 mg sildenafil/kg), over 6 h. Except for the sildenafil application, the control group (11) (n = 4) was treated identically (PGE1 was injected into the PA). One hour after reperfusion, the right main bronchus (MB) and right PA were occluded. Over the next 5 h, cardiopulmonary parameters (systemic aterial, PA, central venous, left atrial. pressure, pCO(2), pO(2)) were measured, including extravascular lung water (EVLW). Thiobarbituric acid-reactive substance assay (TBARS) and myeloperoxidase (MPO) analysis from lung tissue were run. Results: All recipients of group I survived the 6-h reperfusion period; in contrast, all control animals died within 1-2 h after occlusion of the right side. In comparison to a marked rise in pulmonary vascular resistance (PVR) in group 11 (> 1000 dyne s cm(-5)), PVR in group I remained stable, moderately elevated from baseline (baseline: 150180 dyne S cm(-5) vs endpoint: 1000 dyne S cm(-5)). EVI2W in group I did not increase during reperfusion (baseline: 6.75 +/- 1.4 mg/kg vs endpoint: 6.7 +/- 1.0 mg/kg), in contrast to group 11, where pulmonary edema at 2-h reperfusion preceded terminal graft failure (group 1: 9.7 +/- 0.1 mg/kg vs group 11: 6.48 +/- 1.8 mg/kg). Tissue reactive free radicals at endpoint measurement in group I did not differ significantly from native tissue. Yet, when compared to specimen taken from group 11 at time of terminal graft failure, a significant increase in free radicals was noted (group 1: 13.8 +/- 1.6 pmol/g vs group It: 18.5 +/- 3.0 pmol/g, p < 0.05). Conclusion: Sildenafil treatment prevents terminal early graft failure, allowing lung transplantation after 24-h ischemia time. Reperfusion edema was strikingly diminished, preserving pulmonary structural and functional integrity while prolonging graft ischemia time. Employing the established PDE-5 inhibitor sildenafil during lung perfusion, storage, and implantation, ischemic tolerance may be extended and early graft function improved. (c) 2005 Elsevier B.V. All rights reserved.

Sildenafil Extends Survival and Graft Function in a Large Animal Lung Transplantation Model.

Survival and Graft Function in A Large Animal Lung Transplant Model after 30 H Preservation and Substitution of the Nitric Oxide Pathway

New strategies to reduce ischemia/reperfusion injury following lung allotransplantation by substitution of the NO/cGMP pathway

8-Br-cyclic GMP given during reperfusion improves post-transplant lung edema and free radical injury

Attenuation of lung graft reperfusion injury by a nitric oxide donor

8-Br-cyclic GMP Given During Reperfusion Improves Posttransplant Lung Edema and Free Radical Injury

The Nitric Oxide Synthase Cofactor Tetrahydrobiopterin Reduces Allograft Ischemia-Reperfusion Injury after Lung Transplantation.

Combined Treatment with Endothelin- and PAF-antagonists Reduces Posttransplant Lung Ischemia/reperfusion Injury.

Nitroprusside Ameliorates Lung Allograft Reperfusion Injury.

Nitrite Reduces Acute Lung Injury and Improves Survival in a Rat Lung Transplantation Model

Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation

REDUCTION OF LUNG ALLOGRAFT REPERFUSION INJURY BY TETRAHYDROBIOPTERIN (BH4), CO-ENZYME OF Cnos

Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury

Reduction of lung allograft ischemia/reperfusion injury by tetrahydrobiopterin coenzyme of NOS.

Effects of Exogenous Hydrogen Sulfide on Nitric Oxide and Nitric Oxide Synthase During Lung Ischemia-Reperfusion in a Rat Model of Lung Transplantation

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

Scr1slex Ameliorates Ischemia/reperfusion Injury in Experimental Lung Transplantation

Endothelial protection in lung grafts through heparanase inhibition during ex vivo lung perfusion in rats

Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury

C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog

Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation